June 22, 2026 · Form 4 insider transaction
Agarwal Arjun sold 699 shares of Oruka Therapeutics, Inc. at $82.14 per share, a transaction worth $57.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.